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A B S T R A C T   
With the increasing demand for blood transfusions, the production of human hemoglobin (Hb) from sustainable 
sources is increasingly studied. Microbial production is an attractive option, as it may provide a cheap, safe, and 
reliable source of this protein. To increase the production of human hemoglobin by the yeast Saccharomyces 
cerevisiae, the degradation of Hb was reduced through several approaches. The deletion of the genes HMX1 
(encoding heme oxygenase), VPS10 (encoding receptor for vacuolar proteases), PEP4 (encoding vacuolar pro-
teinase A), ROX1 (encoding heme-dependent repressor of hypoxic genes) and the overexpression of the HEM3 
(encoding porphobilinogen deaminase) and the AHSP (encoding human alpha-hemoglobin-stabilizing protein) 
genes — these changes reduced heme and Hb degradation and improved heme and Hb production. The reduced 
hemoglobin degradation was validated by a bilirubin biosensor. During glucose fermentation, the engineered 
strains produced 18% of intracellular Hb relative to the total yeast protein, which is the highest production of 
human hemoglobin reported in yeast. This increased hemoglobin production was accompanied with an increased 
oxygen consumption rate and an increased glycerol yield, which (we speculate) is the yeast’s response to 
rebalance its NADH levels under conditions of oxygen limitation and increased protein-production.   
1. Introduction 
Hemoglobin (Hb) is a major blood-protein, whose main function is 
oxygen transport. In humans, during erythropoiesis in the bone marrow, 
megakaryocyte/erythroid progenitor cells (MEP) produce Hb that is 
carried by differentiated erythrocytes (red blood cells, RBCs) in blood 
circulation (Xavier-Ferrucio and Krause, 2018). Hb is the 
cofactor-containing tetrameric protein that is composed of two α- and 
two β-globin subunits (α2β2) in adults. Each subunit carries one heme b 
(protoporphyrin IX) group with a ferrous iron atom ligated by the four 
nitrogen atoms at the center of the porphyrin ring (Bruice, 2004). While 
the iron atom acts as an active site for oxygen binding, the organic 
component of Hb contributes to the regulation of the Hb activity. For 
example, the organic component ensures the reversibility of the oxygen 
binding to Hb (Nagai et al., 1985). Human Hb is needed for blood 
transfusions and for artificial blood, but in recent years donated blood 
has had shortages, because of decreasing rates of donation. 
As an alternative to human donations of blood, recombinant pro-
duction of Hb is a promising technology, following the success of other 
valuable chemicals. Published research on the recombinant production 
of hemoglobin has reported the use of production hosts from bacteria, 
yeast, plants, and animals (Behringer et al., 1989; Hoffman et al., 1990; 
Wagenbach et al., 1991; Swanson et al., 1992; Dieryck et al., 1997). The 
degradation of hemoglobin in heterologous hosts is a common problem, 
which occurs due to lower stability of α-globin subunit (Kihm et al., 
2002; Feng et al., 2004). In E. coli, the expression of the 
human-hemoglobin genes in a single operon increased the stochiometric 
quantities of α- and β-globins, which are used in Hb folding (Hoffman 
et al., 1990). In E. coli, site-directed mutagenesis increased the solubility 
of Hb (Weickert et al., 1999). In E. coli, the co-expression of the erythroid 
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human α-hemoglobin stabilizing protein (AHSP) increased the yield of 
Hb production (Vasseur-Godbillon et al., 2006). Production of 
heme-containing proteins, particularly hemoglobins, is dependent on 
heme availability (Fibach et al., 1995). Internal availability of heme and 
its precursor 5-aminolevulinic acid (5-ALA) in E. coli are limited. The 
addition of external heme, 5-ALA, and the overexpression of heme 
transporters were reported beneficial for improved hemoglobin pro-
duction in E. coli (Verderber et al., 1997; Graves et al., 2008; Fiege et al., 
2018). The budding yeast Saccharomyces cerevisiae is a traditional model 
microorganism, which has become a preferred cell-factory for many 
products, such as flavors, industrial enzymes, and pharmaceuticals 
(Hong and Nielsen, 2012; Kutyna and Borneman, 2018; Nielsen 2019). 
Unlike in bacteria, for hemoglobin production yeasts do not require the 
external addition of costly heme or heme precursor, 5-ALA. S. cerevisiae 
produces heme endogenously in a complex pathway involving two cell 
compartments, cytosol and mitochondria, and is strictly regulated by the 
carbon source, oxygen, and iron availability (Zhang and Hach 1999; 
Hoffman et al., 2003; Liu et al., 2014). The expression of recombinant 
hemoglobin in yeast has been significantly improved by the strategies on 
enhancing the endogenous heme biosynthesis, balancing α- and β-globin 
gene expression, and also by engineering oxygen sensing (Keng 1992; 
Liu et al., 2014; Martínez et al., 2015). The heme biosynthesis capacity 
was increased by the overexpression of rate-limiting enzymes of the 
pathway (Liu et al., 2014; Martínez et al., 2015). As an example, the 
overexpression of HEM3 gene (encoding porphobilinogen deaminase) 
on multi-copy plasmid results in up to 4-fold increase in intracellular 
free heme and up to 4% of Hb (Liu et al., 2014). The deletion of HAP1 
gene, encoding a transcription factor involved in the regulation of 
cellular respiration and heme biosynthesis, was successful to improve 
the hemoglobin production further, up to 7% of the total cell soluble 
protein content (Martínez et al., 2015). 
We used new approaches to improve human Hb production in yeast, 
which are based on engineering reduced hemoglobin degradation 
(Fig. 1A and B): i) overexpressed the HEM3 gene (encoding porphobi-
linogen deaminase); ii) deleted the ROX1 gene (encoding heme- 
dependent repressor of hypoxic genes) to eliminate inhibition of 
Fig. 1. Construction of yeast strains with reduced degradation of heme and hemoglobin. A) The overview of strains construction. The human adult form of he-
moglobin (HbA) and human alpha-hemoglobin stabilizing protein (the AHSP gene) were expressed in S. cerevisiae Δrox1 strain with modification of heme degradation 
pathway (carrying the HMX1 gene deletion), and reduced targeting of misfolded proteins to vacuole (carrying the VPS10 and PEP4 deletions). B) The deletions of 
VPS10, HMX1, PEP4 genes were introduced sequentially into Δrox1 mutant strain background and their porphyrins production was compared to the wild-type strain 
in SD medium with and without 5-ALA. Each strain was transformed with HbA expression plasmids pIYC04 + HEM3 (HEM3) and pSP-GM1+ ααβ (HbA) or pIYC04 +
HEM3+AHSP ( AHSP) and pSP-GM1+ ααβ (HbA). C) Total porphyrins were assayed using 3 biological replicates, error bars represent standard deviation. Strain #1 
was used to normalize the data. Statistical analysis was performed using one-way ANOVA (*p ≤ 0.03, **p ≤ 0.003). D) ROS accumulation of constructed strains at 24 
h of glucose fermentation detected by dihydrorhodamine 123 staining. Mean fluorescence values of 5000 cells obtained by flow cytometry were compared. Strains: 1- 
WT/empty vectors, control; 2- WT/HEM3/ααβ; 3- Δrox1/HEM3/ααβ, 4 - Δrox1Δvps10/HEM3/ααβ, 5 - Δrox1Δvps10Δhmx1/HEM3/ααβ, 6 - Δrox1Δvps10Δhmx1Δpep4/ 
HEM3/ααβ, 7 - Δrox1Δvps10Δhmx1Δpep4/HEM3+AHSP/ααβ. 
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HEM13 gene (encoding coproporphyrinogen III oxidase) by Rox1; iii) 
deleted the HMX1 gene (encoding heme oxygenase) responsible for 
specific heme cleavage; iv) overexpressed human AHSP gene (encoding 
α-hemoglobin stabilizing protein) for increased stability of the α-globin; 
v) deleted the VPS10 (encoding sorting receptor of vacuolar hydrolases) 
and PEP4 (encoding vacuolar proteinase A) genes for reducing targeting 
of hemoglobin to the vacuoles for protein degradation. Among these 6 
mutations we introduced, the modification of expression the genes 
ROX1, HMX1, VPS10 and AHSP were not used before for hemoglobin 
production in S. cerevisiae. By combining the mutations in one genome, 
we showed their beneficial effect and engineered a novel S. cerevisiae 
strain with substantially reduced hemoglobin degradation and improved 
hemoglobin production, and which produces ~18% of human hemo-
globin of its total protein content on glucose. 
2. Results 
2.1. Improving heme biosynthesis and reducing heme and hemoglobin 
degradation increased the yield of human hemoglobin 
The transcriptional factor Rox1, which is an activator of hypoxic 
genes, is also a repressor of heme biosynthesis. The Rox1 inhibits the 
transcription of the HEM13 gene (Keng 1992). In S. cerevisiae, the 
deletion of the ROX1 gene or the reduction of its expression increase the 
production of heterologous proteins, such as α-amylase and insulin 
precursor (Liu et al., 2015). The deletion of the ROX1 gene increases 
intracellular levels of heme (Zhang et al., 2017). When transformed with 
the plasmids for recombinant hemoglobin expression (pIYC04 + HEM3 
and pSP-GM1+ ααβ, Table S1), the Δrox1 strain accumulated 1.2 times 
more total porphyrins than the wild-type (WT) background strain 
(Fig. 1C). This was visible on the plates supplemented with the heme 
precursor 5-ALA (5-aminolevulinic acid): the Δrox1 strain with hemo-
globin plasmids had a red pigmentation, a consequence of the greater 
porphyrins-accumulation than the WT (Fig. 1B). Consequently, the 
Δrox1 strain was selected for our engineering. 
To increase the production of Hb, we planned to reduce the intra-
cellular degradation of both hemoglobin and heme (Fig. 1A). We deleted 
the VPS10, PEP4, and HMX1 genes in the S. cerevisiae genome and 
overexpressed the human α-hemoglobin-stabilizing protein, which is 
encoded by the AHSP gene (Fig. 1A). The final gene combination was the 
result of sequential experimentation. We experimentally verified the 
impact of each deletion. If the deletion was successful, this new strain 
was further engineered with a new mutation; otherwise, when the mu-
tation was not successful, we continued with alternative genes until we 
reached an apparent local maximum that substantially improved on 
previous results. We chose the VPS10 and PEP4 genes as they affect the 
targeting of misfolded proteins to the vacuole for their vacuolar degra-
dation, and the HMX1 gene is part of the heme-degradation pathway 
(Hong et al., 1996; Protchenko and Philpott, 2003; Marques et al., 
2006). The three gene-deletions (Δvps10, Δhmx1, and Δpep4, Fig. 1B) 
were sequentially introduced into the Δrox1 strain background by the 
Cre-lox system with kanMX as a selective marker. After each deletion, 
the kanMX marker was removed by the induction of Cre-recombinase 
expression (Materials and methods). The human AHSP gene was 
cloned and expressed on the pIYC04 + HEM3 plasmid as a synthetic 
peptide with its codons optimized for expression in S. cerevisiae. The four 
deletion strains were transformed with adult form of hemoglobin (HbA) 
expression plasmids (pIYC04 + HEM3 and pSP-GM1+ααβ or pIYC04 +
HEM3+AHSP and pSP-GM1+ααβ [Table S1]). 
The production of porphyrins and hemoglobin was increased with 
each step (Fig. 1B and C, Fig.S1). In erythrocytes and in E. coli, human 
AHSP prevents the degradation and oxidation of α-globin by forming a 
stable complex with a free α-globin subunit (Kihm et al., 2002; Feng 
et al., 2004; Vasseur-Godbillon et al., 2006; Mollan et al., 2010). In our 
yeast model, the overexpression of AHSP gene increased hemoglobin 
production by 58% (Fig. 2A and B). After 24 h, the total porphyrins level 
in the Δrox1Δvps10Δhmx1Δpep4/HEM3+AHSP/ααβ strain was 2.6 times 
higher than in the WT/HEM3/ααβ strain (Fig. 1C). At 24 h we observed 
that the increased hemoglobin production positively correlated with 
increased ROS production (Fig. 1C and D), as it occurs in other protein 
production strains (Tyo et al., 2012). On the other hand, the AHSP strain 
had slightly reduced level of ROS at the early stage of glucose fermen-
tation, at 6 h (Fig.S2); reduced ROS is associated with antioxidant AHSP 
activity (Kihm et al., 2002; Feng et al., 2004; Mollan et al., 2010). As 
hemoglobin production increased, the growth rate was reduced (Fig.S3), 
likely due to higher protein production in the cell or toxicity of hemo-
globin to yeast or both. After the PEP4 deletion, the α-globin band of 
hemoglobin was detected both by Western blotting and by protein SDS 
gel, which indicated the high production of hemoglobin (Fig. 2, Fig.S1). 
The hemoglobin activity in yeast was detected by the absorption 
Fig. 2. Hemoglobin expressed in yeast and binds carbon monoxide. A) SDS PAGE gel of TCA protein extracts of yeast strains expressing hemoglobin in flasks. The 
arrow indicates the hemoglobin band. B) Western blotting using anti-alpha globin antibodies. Hb-A commercial hemoglobin (control), L1 – Spectra™ Multicolor 
Broad Range Protein Ladder, L2 - PageRuler™ Unstained Protein Ladder. The arrow indicates the hemoglobin band. Hemoglobin production, %, per total protein was 
calculated from hemoglobin band intensity for each strain: #1 - 0%; #2–0.4%; #3–6.7%, and #4–11.6%. C) Absorption spectra of supernatant of yeast crude extracts 
of strain #2 (blue) and strain #4 (orange) treated with CO-releasing compound CORM-3. The arrows indicate the peak of carboxyhemoglobin. Strains: 1- WT/empty 
vectors, control; 2- WT/HEM3/ααβ; 3- Δrox1Δvps10Δhmx1Δpep4/HEM3/ααβ, 4- Δrox1Δvps10Δhmx1Δpep4/HEM3+AHSP/ααβ. . (For interpretation of the references 
to color in this figure legend, the reader is referred to the Web version of this article.) 
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spectra of carboxyhemoglobin (Hb-CO) formed after the treatment of 
cellular extracts with carbon monoxide-generating compound (CORM- 
3) (Fig. 2C). The strain Δrox1Δvps10Δhmx1Δpep4/HEM3+AHSP/ααβ 
had a CORM-3 treated cell-free extract with an absorption peak at 419 
nm (corresponding to the Hb-CO), which was 3.1-times greater than the 
peak of the CORM-3 treated extract from the WT/HEM3/ααβ strain 
(Fig. 2C). 
2.2. The hemoglobin and heme degradation product bilirubin was 
diminished 
Our engineered strains were analyzed for the accumulation of the 
hemoglobin degradation product, bilirubin, using a bilirubin-binding 
biosensor the UnaG protein from an eel muscle (Kumagai et al., 2013). 
The mCherry-UnaG fusion from the plasmid mCherry-FDD (Navarro 
et al., 2016) was cloned under the yeast promoter PGK1 on the vector 
pIYC04 + HEM3 (Table S1). The constructed plasmid pIYC04 +
HEM3+mCherry-UnaG (Table S1) was transformed into the four 
deletion-strains and the wild-type strain to estimate the effect of the 
introduced mutations on bilirubin formation (Fig. 3A). Upon 100 μM 
Fe3+ supply, the WT strain had the highest fluorescence yield at 12 h of 
growth, which provided a standard for the successive deletion-strains. 
First, the ROX1 deletion had the lower fluorescence during fist 10 h of 
growth but after 15 h the fluorescence was higher than in WT strain 
(Fig. 3B). The rox1 mutation increases the expression of anaerobic genes 
(Ter Linde and Steensma, 2002). Second, the additional VPS10 deletion 
reduced the fluorescence by ~40% (Fig. 3B). Third, the additional 
deletion of the HMX1 gene in the rox1vps10 background reduced the 
fluorescence further by ~40% (Fig. 3B); HMX1 encodes the heme oxy-
genase that catalyzes the formation of bilirubin’s precursor biliverdin. In 
contrast, the deletion of the PEP4 gene in the rox1vps10 background 
strain did not significantly affect the bilirubin formation (Fig. 3B). The 
fusion hemoglobin, which is a more stable hemoglobin form (Chakane, 
2017; Chakane et al., 2017), had less fluorescence of the bilirubin 
biosensor and thus less bilirubin than HbA form (Fig.S4). 
2.3. Strains with increased hemoglobin-production had increased cell-size 
and cell-density 
The AHSP strain (Δrox1Δvps10Δhmx1Δpep4/HEM3+AHSP/ααβ) 
with increased hemoglobin production increased its average cell-size 
(Fig. 4). Larger cells contain more proteins (Marguerat and Bähler, 
2012.). Forcing the high production of protein hinders ribosomal ac-
tivity, so the yeast decreases the growth rate and increases the cell size 
(Kafri et al., 2016). In our study, the cell length was 30% greater in the 
AHSP strain than in the control strain WT/HEM3/ααβ (Fig. 4A). Flow 
cytometry analysis by both side-scattered and forward-scattered light 
showed two populations, the AHSP strain and control strain 
WT/HEM3/ααβ (Fig. 4B), suggesting that they have different cell size or 
cell density. This suggestion was confirmed by the results of the cell 
sorter, which showed that the AHSP strain had cell diameter and cell 
volume 1.2- and 1.8-times (respectively) greater than the control strain 
WT/HEM3/ααβ (Fig.4C, Fig.S5). The AHSP strain had the greatest 
cell-volume (Fig. 4, Fig.S5). However, the intermediate strain 
Δrox1Δvps10Δhmx1Δpep4/HEM3/ααβ, which produced 58% lower Hb 
than AHSP (Fig. 2B), had a cell-size from 10% to 36% higher than 
control strain, WT/HEM3/ααβ (Fig.S5). 
2.4. Iron supplementation increased recombinant hemoglobin production 
and reduced bilirubin formation 
The final step of heme biosynthesis in S. cerevisiae is the incorpora-
tion of iron into the porphyrin ring by a ferrochelatase encoded by the 
HEM15 gene (Labbe-Bois, 1990). Doubling the iron concentration in the 
medium increased porphyrin synthesis 25% and the hemoglobin protein 
production 1.5-fold in AHSP strain (Fig.S6). Finally, increasing 2-fold 
the concentration of iron (Fe3+) decreased the formation of bilirubin 
by ~12% (Fig.S6). 
2.5. Hemoglobin production increased in bioreactors 
The hemoglobin production in the constructed strains was studied in 
batch bioreactors with constant aeration and pH (Materials and 
Fig. 3. Bilirubin biosensor expressed in yeast. A) The mCherry-UnaG construct was expressed in yeast under promoter PGK1 to study the accumulation of heme/ 
hemoglobin degradation product bilirubin. The construct is fluorescent when bilirubin is present but is degraded when no bilirubin is formed. B) mCherry-UnaG 
green fluorescence yield (fluorescence normalized by biomass) in different strains expressing HbA: wild-type (Strain 2, blue); Δrox1 (Strain 3, green); 
Δrox1Δvps10 (Strain 4, red); Δrox1Δvps10Δhmx1 (Strain 5, purple); Δrox1Δvps10Δpep4 (Strain 6, gold). Wild-type strain expressing empty vector was used as a control 
(Strain 1, black). Each strain was grown in SD his-ura- medium with 2% glucose and 100 μM Fe3+ and was analyzed in BioLector® bioreactor. Error bars represent 
standard deviation of 4 biological replicates. . (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of 
this article.) 
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Methods). Under these controlled conditions, the maximum specific 
growth rate of the AHSP strain was 20% less than that of the control 
strain WT/HEM3/ααβ (Table S2). The AHSP strain increased the yields 
of glycerol 100% and acetate 30%, while it increased the oxygen con-
sumption rate 15% and decreased the CO2 yield 6% (Table S2). In the 
AHSP strain, the increased glycerol, acetate-production, and oxygen- 
consumption-rate replicated the general finding that these changes 
indicate that the cell is coping with the redox imbalance (van Dijken and 
Scheffers, 1986). In the bioreactors, after 48 h of cultivation, the AHSP 
strain produced 18% of its total protein content in hemoglobin (Western 
blot). This Hb-production was 500% greater than in the control strain 
WT/HEM3/ααβ (Fig. 4E). The intermediate strain, 
Δrox1Δvps10Δhmx1Δpep4 lacking AHSP protein, produced only ~8% of 
Hb of its total protein content (Fig.S7), while the control strain, 
WT/HEM3/ααβ, accumulated ~3–4% of intracellular hemoglobin (Liu 
et al., 2014), a result that we replicated (Fig. 4E). In the AHSP strain, 
after 24 h 12% of its total cellular protein was hemoglobin concurrently 
increasing the total cell protein content by 6%; after 48 h, 18% of its 
total cellular protein-content was hemoglobin, concurrently increasing 
the total protein content of the cell by 21% (Fig.4E, Fig.S8). 
2.6. Reducing hemoglobin degradation increases hemoglobin secretion 
Adapting the hemoglobin fusion construct for the bacterium E. coli 
(Chakane et al., 2017) for use in yeast, we first codon-optimized it for 
yeast expression and then fused it to the yeast α-factor leader-sequence 
to target hemoglobin to the endoplasmic reticulum (ER) and the secre-
tory pathway for extracellular secretion through the transport vesicles 
(Rexach et al., 1994). The α-factor leader-hemoglobin fusion-construct 
was expressed in three strains: INVSc1 (Invitrogen’s diploid strain for 
protein expression), 184M (an amylase producer developed for secretion 
by mutagenesis [Huang et al., 2015]), and our Δrox1Δvps10Δhmx1Δpep4 
(mutant of CENPK113-11c with reduced hemoglobin degradation) 
[Fig. 5A]. No hemoglobin was detected before the concentration of the 
medium. However, after concentrating the strains’ media using Amicon 
10 kDa centrifugation filters (Merck Millipore), hemoglobin was 
detected by Western blotting in two strains, 184M and Δrox1 
Δvps10Δhmx1Δpep4 (but not in INVSc1) Fig. 5B. In both these strains, 
Fig. 4. AHSP strain had increased cell size and complexity. A) Phase contrast microscope images showing cell size of hemoglobin strains (WT and AHSP). Scale bar 
represents 10 μm. B) Flow cytometry analysis of 5000 cells shows two cell populations for WT (red) and AHSP (blue) strains. Cell diameter (C) and cell volume (D) 
estimated by CASY Model TT Cell Counter for WT and AHSP strains. E) Estimation of hemoglobin production during cultivation in bioreactors of WT and AHSP 
strains by Western blotting using anti-hemoglobin α antibodies. Hb, % was calculated by band intensity normalized by total protein loaded in each lane. The error 
bars represent standard deviation of two replicates. The AHSP was found to produce significantly greater Hb amount as estimated by one-way ANOVA (12 h: *p ≤
0.03; 18 h: *p ≤ 0.04; 27 h: **p ≤ 0.007; and 48 h: **p ≤ 0.002). Strains: WT- WT/HEM3/ααβ; AHSP - Δrox1Δvps10Δhmx1Δpep4/HEM3+AHSP/ααβ. . (For inter-
pretation of the references to color in this figure legend, the reader is referred to the Web version of this article.) 
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the protein band of ~30 kDa corresponding to fusion hemoglobin was 
detected; however, in the 184M strain, 4 smaller bands were addition-
ally observed (Fig. 5B), which may indicate the partial degradation of 
hemoglobin in the 184M strain, we speculate. The 184M strain has 
mutations that down-regulate the ROX1 and VPS10 introduced by 
mutagensis; its PEP4 and HMX1 gene-expressions were unchanged 
(Huang et al., 2017). 
3. Discussion 
Hb contains common prosthetic group (heme b), which is incorpo-
rated into the globin chains co-translationally and important for the 
polypeptide-folding (Komar et al., 1993). Heme availability is not only 
crucial for hemoglobin synthesis but for its major function, because a 
heme-less hemoglobin will be unable to bind oxygen. 
To improve heme availability, we overexpressed the heme biosyn-
thesis gene HEM3, which limits the biosynthesis of heme. The gene 
HEM3 increases both heme and hemoglobin production (Hoffman et al., 
2003; Liu et al., 2014). Under the overexpression of the HEM3 and 
human hemoglobin genes, the Δrox1 strain produced more porphyrins. 
The intracellular level of heme is tightly regulated in response to the 
oxygen availability by the transcription factor Hap1, which activates the 
Rox1. In turn, Rox1 represses the expression of the HEM13 gene (Keng 
1992; Ter Linde and Steensma, 2002). In S. cerevisiae, the deletion of the 
ROX1 gene increases heme-production (Zhang et al., 2017), activates 
hypoxia-induced genes (Keng 1992), and increases the production of 
other heterologous proteins, such as insulin, invertase, and α-amylase 
(Liu et al., 2015). 
Heterologous-protein synthesis is inhibited by the protein degrada-
tion mechanisms in the host, and consequently these processes’ sup-
pression increases protein-production. Outside the erythrocytes and 
without erythroid protective enzymes, the hemoglobin is degraded to 
globin and heme. Released heme is further degraded to biliverdin and 
bilirubin. Heme is naturally produced by yeast and is degraded when it 
is in access or upon iron limitations (Protchenko and Philpott, 2003). To 
suppress the protein-degradation processes, we engineered a 
hemoglobin-producing S. cerevisiae strain with reduced degradation of 
both the hemoglobin protein and its heme cofactor. Engineered with the 
ROX1, VPS10, HMX1, and PEP4 gene-deletions, our yeast produced 
enough hemoglobin to be detected on the protein gel even without 
Western blotting while the degradation product of hemoglobin and 
heme bilirubin was reduced. 
These four gene-deletions have already been found important in 
yeast biology. The heme oxygenase (encoded by the HMX1 gene) 
Fig. 5. Expression of hemoglobin fusion through secretory pathway in different yeast strains. A) Hemoglobin was expressed as a fusion peptide (αɣ-globin Hb fusion 
with S. cerevisiae native α-factor leader sequence) in CENPK113-11c Δrox1Δvps10Δhmx1Δpep4, 184M, and INVSc1 strains. CENPK113-11c carrying empty vector was 
used as a control. B) SDS protein gel and Western blotting with polyclonal antibodies against ɣ-globin chain were used to detect the fusion Hb (αɣ-globin, 33 kDa) 
construct after α-factor leader removal in secretory pathway. Media from the yeast cultures were concentrated using TCA and acetone either 30- or 360-fold. 
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degrades heme upon iron starvation and oxidative stress (Protchenko 
and Philpott, 2003). Under conditions of high protein production, mis-
folded proteins are targeted to the vacuole degradation. The VPS10 
gene, encoding type I transmembrane sorting receptor for multiple 
vacuolar hydrolases, is involved in vacuolar targeting of unfolded pro-
teins (Marcusson et al., 1994). The VPS10 gene’s deletion of the VPS10 
gene increases the production of other heterologous proteins (Hong 
et al., 1996), as does its suppression (Huang et al., 2017). The PEP4 gene 
encodes a vacuolar aspartyl protease, which is important for the recy-
cling of the proteins damaged by oxidative stress. The mutation of the 
PEP4 gene increased the production of heterologous proteins in yeast 
(Marques et al., 2006; Wang et al., 2007). Introducing the deletions of 
VPS10 and HMX1 genes decreased the formation of the hemoglobin 
degradation-product bilirubin, as confirmed by the bilirubin biosensor. 
In our strains, doubling the iron-concentration increased the 
hemoglobin-yield and reduced the bilirubin-formation. The heme- 
oxygenase expression is regulated by iron and oxidative stress (Protch-
enko and Philpott, 2003), and this expression is decreased in the me-
dium with a doubled iron-concentration and in Δrox1. 
Hemoglobin production was increased 58% by the overexpression of 
the human AHSP gene (α-hemoglobin stabilizing protein), which pre-
vents its degradation and oxidation in erythrocytes (Kihm et al., 2002; 
Feng et al., 2004; Mollan et al., 2010). This AHSP-overexpression also 
reduced the ROS formation during the glucose-phase of fermentation. 
Our engineered AHSP-strain produced the hemoglobin level 18% 
with respect to the total intracellular protein content. This was 2.6 times 
greater than the 7% previously reported (Martínez et al., 2015). This 
increased level of hemoglobin was associated with cells having an 
increased volume and an increased protein-content while having a 
3-fold decrease in the growth rate. Such phenotypic changes occur in 
cells burdened with increased protein-synthesis (Kafri et al., 2016). 
The engineered strain carried the mutation of Δhmx1 (causing iron 
depletion) and had overexpressed hemoglobin-genes (causing iron 
depletion). Hemoglobin production was increased by doubling the iron 
concentration in the media. When cells are deprived of iron, their 
respiratory-chain malfunctions and the cells accumulate NADH; such 
stressed cells respond by increasing the expression of the GPD2 gene, so 
producing glycerol (Ansell and Adler, 1999). Increased the intracellular 
production of hemoglobin changed the fermentation profile. The AHSP 
strain increased oxygen-consumption; it also increased the production of 
glycerol and acetate, which are produced to satisfy NADH/NADPH 
balance (Villadsen, et al., 2011). This cofactor imbalance could be 
addressed to improve the hemoglobin-production in the future. 
In conclusion, we engineered a Saccharomyces cerevisiae strain that 
produced 18% (of total cell protein) as human hemoglobin. This strain 
could be used as a sustainable and safe source of hemoglobin for the 
development of hemoglobin-based oxygen carriers (HBOCs) or meat 
substitutes. 
4. Materials and Methods 
4.1. Media and strains growth conditions 
Strains used in this study are listed in Table S3. The strains of 
Saccharomyces cerevisiae CEN.PK 113-11C (MATa his3Δ1 ura 3–52 
MAL2-8c SUC2) (Entian and Kötter, 1998) and its Δrox1 mutant (Liu 
et al., 2015) were used as hosts for human hemoglobin production. Yeast 
strains were maintained at 30 ◦C in a complete rich medium YPD (5 g/L 
yeast extract, 10 g/L peptone, 20 g/L glucose). Transformants with he-
moglobin A expression plasmids pIYC04 + HEM3 and pSP-GM1+ααβ 
(Liu et al., 2014) were selected on synthetic complete medium SD 
without both uracil and histidine (6.9 g/L yeast nitrogen base with 
ammonium sulphate w/o amino acids (Formedium™), 0.75 g/L syn-
thetic complete drop-out mixture w/o histidine and uracil (For-
medium™), pH 6.0) containing 20 g/L glucose as carbon source. 
Additional iron was added to the SD medium (SD with Fe3+) (100 μM of 
ferric citrate, Sigma-Aldrich). Deletion mutants were selected on YPD 
medium with G418 at the concentration of 0.2 g/L. For kanMX marker 
removal by Cre recombinase induction, transformants were grown on 
YPG medium (5 g/L yeast extract, 10 g/L peptone, 10 g/L galactose) 
overnight. For the evaluation of porphyrin production in Δrox1 strain, 
5-aminolevulinic acid (5-ALA) was added in SD media at the concen-
tration of 1 mM. 
4.2. Generation of gene knockout strains 
Oligonucleotide primers and plasmids used in this study are listed in 
Table S1. The deletion cassettes with the dominant selection marker 
kanMX expressed under control of Ashbya gossypii TEF1 (Steiner and 
Philippsen, 1994) were used for the gene knockouts. The subsequent 
marker removal was done by the Cre-lox system (Cre recombinase was 
expressed under promoter GAL1 of S. cerevisiae). The deletion cassettes 
carried kanMX and Cre-recombinase flanked with LoxP and ~50 bp of 
nucleotide sequences homologous to HMX1, VPS10, and PEP4 target 
genes of S. cerevisiae. Each deletion cassette was amplified in 2 fragments 
from template plasmids pDel1 and pDel2 (Table S1 [Wenning et al., 
2017],), containing 335 bp overlapping region of kanMX gene to be 
repaired in vivo in yeast after the transformation (fragment 1): target 
gene 5′-sequence-loxP-half kanMX gene; fragment 2: kanMX gene (sec-
ond half with overlap)-GAL-promoter-Cre recombinase-LoxP-target 
gene 3′ sequence, that were then co-transformed into Δrox1 mutant. The 
HMX1 gene deletion cassette was amplified by Del-HMX1-1 and 
Del1-rev primers pair (PCR fragment 1), Del2-for and Del2-HMX1-2 
(PCR fragment 2). The VPS10 gene deletion cassette was amplified by 
VPS10-1 and Del1-rev (PCR fragment 1), Del2-for and VPS10-2 (PCR 
fragment 2). The PEP4 gene deletion cassette was amplified by PEP4-4 
and Del1-rev (PCR fragment 1), Del2-for and PEP4-2 (PCR fragment 2) 
(Table S1). The transformants with deletion cassettes were selected on 
YPD medium with G418 at the concentration 0.2 g/L. The gene deletions 
were verified by PCR analysis and obtained mutants were selected for 
further studies. To induce the Cre recombinase expression, the trans-
formants were grown overnight in rich medium with galactose (YPG) 
and then plated on YPD. The transformants, that lost the ability to grow 
on YPD with G418 after this treatment, were selected for further studies. 
4.3. Glucose fermentations and metabolites analysis 
Batch glucose fermentations were performed in flasks and under 
strictly controlled conditions in bioreactors. The shake flask fermenta-
tions were performed at 30 ◦C in 25 ml of liquid medium at 200 rpm, 
inoculated with an initial OD600 of 0.2 from the pre-cultures. The batch 
fermentations were performed in 1.0 L Biostat Qplus© bioreactors 
(Sartorius Stedim Biotech, Germany) with a working volume of 500 ml. 
The temperature was maintained at 30 ◦C and pH at 6.0. Bioreactors 
were inoculated with an initial OD600 of 0.1 from the pre-cultures. The 
amount of dissolved oxygen was measured by oxygen sensors and 
maintained above 30%. The volumetric flow (aeration) was set to 60 L/h 
(2 vvm) and constant agitation stirrer speed at 600 rpm. The dry weight 
was measured by collecting the biomass on membrane filters (0.45 μm, 
MontaMil® MCE, Frisenette, Denmark) with subsequent drying. The 
metabolites in the cultivation media were measured in the cultivation 
media by HPLC (Dionex Ultimate 3000 HPLC (Model 1100–1200 Series 
HPLC System, Agilent Technologies, Germany) with HPX-87H column 
(BIO-RAD, USA)). The off-gas from the bioreactors was passed through a 
foam-trap and analyzed by a mass spectrometer (Model Prima PRO 
Process MS, Thermo Fisher Scientific™, United Kingdom). 
4.4. ROS detection 
The ROS level was measured in vivo using the dihydrorhodamine 123 
dye by the protocol described before (Johansson et al., 2016.). For this 
purpose, after 6 h of fermentation, the cells were harvested by 
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centrifugation and washed with 50 mM sodium citrate buffer. The cells 
were further incubated with 50 mM sodium citrate buffer supplemented 
with 50 μM dihydrorhodamine 123 for 30 min in the dark. After stain-
ing, the cells were spun down and washed with 50 mM sodium citrate 
buffer. The formation of rhodamine (oxidized form of dihydrorhod-
amine 123) was detected by fluorescence using the FLUOstar Omega 
microplate reader (with the excitation 485 nm and emission 520 nm 
filters) and Guava easyCyte™ 8HT flow cytometer (Millipore). 
4.5. Porphyrins content analysis 
Cellular heme and porphyrin content were determined as described 
before (Liu et al., 2014). Free cellular heme and total porphyrin content 
was determined after oxalic acid treatment by their fluorescence with 
excitation at λ = 400 nm and emission at λ = 600 nm on a FLUOstar 
Omega plate reader spectrophotometer. 
4.6. Detection of carboxyhemoglobin by absorption spectra 
The buffer to obtain cells crude extracts using glass beads contained 
100 mM potassium phosphate with protease inhibitor cocktail (Fisher 
Scientific), CO-releasing compound CORM-3 (Sigma-Aldrich) at 0.6 mg/ 
ml, 2 mM MgCl2, 1 mM dithiothreitol and 1 mM EDTA. After cells debris 
removal, the carboxyhemoglobin amount was determined by spectra 
analysis of protein extracts of samples with the same protein concen-
tration (13 mg/ml). 
4.7. Determination of cell volume 
The yeast cell volume was determined using CASY Model TT Cell 
Counter and Analyzer (Roche Diagnostics International Ltd). Cells were 
collected from bioreactors at 24, 48, 72 and 96 h of cultivation, re- 
suspended in CASY ton buffer and analyzed using capillary of 60 μm. 
4.8. Protein extraction and Western blotting 
Total protein was extracted by TCA treatment as described in 
(Baerends et al., 2000) and proteins separated by electrophoresis on 
precast SDS–polyacrylamide gels (4–20% gradient, Mini-PROTEAN® 
TGX Stain-Free™ Precast Gels, BIO-RAD), electro-transferred to PVDF 
membrane (Trans-Blot®Turbo Mini PVDF Transfer Packs, BIO-RAD) and 
hybridized with anti-hemoglobin antibodies (Hemoglobin α antibody 
(D-16): sc-31110, goat polyclonal, Santa Cruz Biotechnology). For he-
moglobin signal detection, secondary antibodies were used conjugated 
with either alkaline phosphatase (Anti-goat IgG, Sigma-Aldrich) or 
horseradish peroxidase (Anti-goat IgG, Fisher-Scientific). The signal 
intensity was analyzed in Image Lab ™ (BIO-RAD). 
Statistical analysis 
The software packages R (Version 3.6.1 [R Development Core Team 
(2008). R: A language and environment for statistical computing. R 
Foundation for Statistical Computing, Vienna, Austria]) and MinitabR 
18.1 were used to analyze the data. 
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